LLS, the Mark Foundation for Cancer Research and the Paul G. Allen Frontiers Group Partner to Award $6.75M in New Grants to Drive the Next Wave of Novel Cancer Therapies
July 02, 2020
July 02, 2020
RYE BROOK, New York, July 2 -- The Leukemia and Lymphoma Society issued the following news release:
Seeking to ignite the next major breakthroughs to treat blood cancers, The Leukemia & Lymphoma Society (LLS), The Mark Foundation, and The Paul G. Allen Frontiers Group announced more than $6.75 million awarded to nine of the most exceptional scientists in the field.
The innovative Blood Cancer Discoveries Grant Program is designed to encourage researchers with deep e . . .
Seeking to ignite the next major breakthroughs to treat blood cancers, The Leukemia & Lymphoma Society (LLS), The Mark Foundation, and The Paul G. Allen Frontiers Group announced more than $6.75 million awarded to nine of the most exceptional scientists in the field.
The innovative Blood Cancer Discoveries Grant Program is designed to encourage researchers with deep e . . .